Skip to main content

Table 1 Characteristics of participants in the BC HIV/AIDS Drug Treatment Program by era of HAART initiation

From: Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study

ERA (n)

1996-98

(967)

1999-01

(897)

2002-04

(783)

2005-07

(1074)

p-value

N (%) Male

829(85.7)

694(77.4)

630(80.5)

863(80.4)

< 0.001

N (%) with history of ever using injection drugs

387(40)

341(38)

305(39)

423(39.4)

0.842

Median age (IQR)

37 (32-43)

38 (33-45)

42 (35-48)

42 (36-49)

< 0.001

Median CD4 cell count

(IQR)

280

(120-430)

190

(80-330)

150

(70-230)

180

(100-250)

< 0.001